TERRANCE MCGUIRE
CIK 1117003 · last filed 2026-05-21
TERRANCE MCGUIRE is a corporate insider who has filed 114 SEC Form 4 insider transactions across 14 companies since 2007. The most recent filing, for IVVD, was dated May 21, 2026. Across all open-market trades the lifetime net is −$254.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$20.25M
14
114
-$254.34M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IVVD | Director | 3,170,231 | $0.59 | $1.88M | -$1.02M | 10 | 2026-05-21 |
| SEER | Director | 191,013 | $2.15 | $410.7K | $1.50M | 8 | 2025-12-11 |
| TECX | Director | 20,262 | $29.86 | $605.0K | -$8.55M | 2 | 2025-06-11 |
| CYCN | Director | 5,897 | $3.55 | $20.9K | $10.32M | 9 | 2023-12-04 |
| ALEC | Director | 10,908,813 | $1.52 | $16.64M | -$3.14M | 11 | 2023-09-13 |
| Invivyd, Inc. (ADGI) Delisted | Director | 31,198 | $4.64 | $144.8K | $8.50M | 4 | 2022-06-24 |
| PULM | Director | — | $1.68 | — | $0 | 5 | 2019-05-20 |
| IRWD | Director | 142,747 | $3.85 | $548.9K | -$19.0K | 35 | 2019-04-03 |
| IRONWOOD PHARMACEUTICALS INC (IRWDV) Delisted | Director | 146,803 | — | — | $0 | 1 | 2019-03-19 |
| X4 Pharmaceuticals, Inc (ASNS) Delisted | Director | 1 | $0.08 | $0 | $5.00M | 4 | 2018-06-07 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 1,250 | $178.75 | $223.4K | -$25.72M | 18 | 2017-03-14 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 4,278 | $5.54 | $23.7K | -$1.21M | 2 | 2013-06-19 |
| TTGT | 10%+ Owner | 31,629 | $4.55 | $143.9K | -$240.00M | 1 | 2010-12-10 |
| DECODE GENETICS INC (DCGN) Delisted | Director | 117,516 | — | — | $0 | 3 | 2008-12-16 |
Recent Filings
114 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | IVVD | Grant (A) | — | $0 | EDGAR |
| 2025-12-11 | SEER | Conv (C) | +4,088 | $0 | EDGAR |
| 2025-07-09 | SEER | Grant (A) | +20,500 | $0 | EDGAR |
| 2025-06-11 | TECX | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | IVVD | Grant (A) | — | $0 | EDGAR |
| 2025-04-07 | TECX | Sell (S) | −500,000 | -$8.55M | EDGAR |
| 2024-12-31 | IVVD | Sell (S) | −273,763 | -$131.5K | EDGAR |
| 2024-12-26 | IVVD | Sell (S) | −347,559 | -$164.9K | EDGAR |
| 2024-12-19 | IVVD | Sell (S) | −324,241 | -$147.8K | EDGAR |
| 2024-12-16 | IVVD | Sell (S) | −190,359 | -$103.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.